The first goal of this study was to investigate whether totally pancreatectomized patients are glucagon deficient and if so, to what degree. Immunoreactive glucagon (IRG) concentrations in peripheral plasma of nine pancreatectomized patients were not significantly different from those of 10 normal controls as measured by two antisera (30-K and RCS-5) both detecting the COOH-terminal portion of the molecule and one (RCS-5) postulated to be specific for pancreatic glucagon. Plasma from six of nine pancreatectomized patients were fractionated over Sephadex G-50 and IRG was measured with both antisera in the column eluates. Using 30-K, 80.8 +/-9% of the IRG eluted within the void volume. This material was rechromatographed on Sephadex G-200 and found to have an apparent mol wt of approximately 200,000. Only 18.3 +/-9% eluted in the IRG3500 region. IRG3500 was significantly reduced in pancreatectomized patients as compared to normal controls (49 +/-9 vs. 18 +/-9 pg/ml, P less than 0.05). Using RCS-5, all IRG (corresponding to 20 +/-6 pg/ml of plasma) eluted in the IRG3500 region. The second goal of this study was to investigate the effects of chronic glucagon deficiency on plasma amino acids. In the nine pancreatectomized patients studied, postabsorptive plasma concentrations of serine, alanine, arginine, glycine, threonine, citrulline, alpha-aminobutyrate, and tryosine were significantly elevated compared to values obtained from 20 […] gon (6.25 and 8.0 ,g/h, respectively) resulted in normalization of the hyperaminoacidemia within 22 h. We con-This work has been presented, in part, at the 38th Annual
A B S T R A C T The first goal of this study was to investigate whether totally pancreatectomized patients are glucagon deficient and if so, to what degree. Immunoreactive glucagon (IRG) concentrations in peripheral plasma of nine pancreatectomized patients were not significantly different from those of 10 normal controls as measured by two antisera (30-K and both detecting the COOH-terminal portion of the molecule and one (RCS-5) postulated to be specific for pancreatic glucagon. Plasma from six of nine pancreatectomized patients were fractionated over Sephadex G-50 and IRG was measured with both antisera in the column eluates. Using 30-K, 80.8+9% ofthe IRG eluted within the void volume. This material was rechromatographed on Sephadex G-200 and found to have an apparent mol wt of -200,000. Only 18.3+9% eluted in the IRG3500 region. IRG3500 was significantly reduced in pancreatectomized patients as compared to normal controls (49+9 vs. 18+9 pg/ml, P < 0.05). Using RCS-5, all IRG (corresponding to 20±6 pg/ml of plasma) eluted in the IRG3500 region. The second goal of this study was to investigate the effects ofchronic glucagon deficiency on plasma amino acids. In the nine pancreatectomized patients studied, postabsorptive plasma concentrations of serine, alanine, arginine, glycine, threonine, citrulline, a-aminobutyrate, and tryosine were significantly elevated compared to values obtained from 20 normal controls. Physiological glucagon increments produced in two pancreatectomized patients by infusion of gluca- INTRODUCTION It has recently been shown that glucagon plays an important role in the control of glucose homeostasis (1) and ketone body production (2) in human subjects. Moreover,Unger and Orci (3) have described diabetes mellitus as a bihormonal disease characterized not only by insulin deficiency but also by glucagon excess. This view has been challenged by Barnes and Bloom (4) who found that totally pancreatectomized patients had no circulating plasma immnunoreactive glucagon (IRG)' but readily developed hyperglycemia and ketoacidosis if deprived of exogenous insulin. Others, however, have detected varying amounts of glucagon in plasma of pancreatectomized patients (5) (6) (7) (8) . Thus, the solution to the question of whether or not glucagon remains in circulation of patients after total pancreatectomy has becomne important for the evaluation of the role ofglucagon in the pathogenesis ofdiabetes mellitus.
There is also some evidence to suggest that glucagon, besides its effects on glucose and ketone metabolism, may play an important role in human amino acid metabolism. For instance, infusion of large glucagon doses lowers plasma amino acids (9) ; patients with glucagon-IAbbreviations used in this paper: IRG, imuntinoreactive glucagon; IRG3500, 3500-dalton IRG; NPH, neuitral protamine Hagedorn (instilin). secreting islet cell tumors (glucagonoma) have severely depressed blood amino acid levels and advanced muscle wasting (10, 11) . However, this aspect of glucagon action has been relatively neglected and the evidence remains incomplete. Most of the previous work was done with pharmacological doses of glucagon and the significance of these studies for human physiology can be seriously questioned (12) . Sherwin et al. (13) infused glucagon into normal overnight-fasted volunteers at a rate of 3 nglkg per min, which raised plasma glucagon concentrations from about 100 pg/ml to slightly above 300 pg/ml. They observed no consistent changes in amino acid concentrations except for a 7% decrease in serine concentration during the 150-180-min infusion period. Doubling of the infusion rate, however, resulted in a 10-19% reduction in glycine, serine, and threonine concentrations. Effects of infusions of physiologic doses of glucagon on plasma amino acids have also been studied in obese subjects after prolonged fasting (14) . Results in this group can be expected to be different because obesity (15) as well as fasting (16) have effects of their own on amino acid metabolism. The effects of glucagon deficiency on amino acids have never been studied. It appears, therefore, that the evidence for a physiologic role of glucagon in amino acid metabolism could be strengthened considerably if it could be demonstrated that chronic glucagon deficiency has effects that are opposite to those seen during chronic glucagon excess (glucagonoma).
This study was, therefore, designed to answer the following questions: (a) Are pancreatectomized patients glucagon deficient, and if so, to what extent? (b) Do these patients have abnormal amino acid profiles, and if so, can these abnormalities be related to glucagon deficiency?
METHODS
Patients. Clinical data on the nine pancreatectomized patients (three males, six females) studied are listed in Table I . All underwent total pancreatectomy, duodenectomy, gastrectomy, and splenectomy. In addition, three had partial jejunostomy, five had cholecystectomny, and three had vagotomy. The reasons for these procedures were: adenocarcinoma in six patients, recurrent pancreatitis with intractable pain, insulinoma, and suspected vipoma in one patient each. Preoperatively, (19, 20) . For the assay, 0.25 ml of plasmiia or 0.9 ml of column eluate were added to 0.75 ml or 0.1 ml of assay buffer, respectively. Sensitivity with the 30-K antiserum was 20 pg/ml of plasma and 6 pg/ml of column eluate. Using the RCS-5 antiserum, sensitivity was between 5 and 10 pg/mi of plasma and 2-3 pg/ml of column eluiate.
Gelfiltration. Sufficient plasma was available for fractionationl fromi six of the nine patients. 5-mil samples of postabsorptive plasma were lyophilized, redissolved in 3 ml of borate buffer (0.05 M, pH 8.0) and gel filtrated over Sephadex G-50 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) fine columns (1.5 x 90 cm) as described (11). 2-mil fractions were collected, of which 0.9-mil aliquots were uised for glucagon assays using the 30-K and the RCS-5 antisera. The void volumes froim the Sephadex G-50 coluinns ofthree pancreatectomized patients (V.B., E.G., C.C.) were individually pooled, lyophilized, redissolved in 3 ml of borate buffer, and gel filtrated over Sephadex G-200 columns (1.5 x 90 cm). Equlilibration, elution buffer, collection, and assay of eluates were as described for the Sephadex G-50 fractionations. The flow, rate was 6 ml/h. The following column markers were used: fibrinogen (330-103), catalase (200 103), lactate dehydrogenase (140-103), malate dehydrogenase (70 103), and 1251odine (salt peak marker).
Glucagon infusions. Two patients (E.G. and V.B.) received glucagon (beef-pork, Eli Lilly & Co., Indianapolis, Ind.) by contintuous intravenous infuision at rates of 6.25 and 8.0 ,ug/h for 24 and 22 h, respectively. During the glucagon infusion E.G. received two injections of neutral protamine Hagedorn insulin (20 U before breakfast and 10 U before dinner). V.B. received regular insulin by continuous infusion (2.4 U/h between 8 a.m. and 8 p.m., and 1.2 U/h between 8 p.m. and 6 a.m.). E.G. consumed 1,720 cal (carbohydrates, 196 g; protein, 177 g; fat, 52 g), whereas V.B. consumed 2,134 cal (carbohydrates, 196 g; protein, 112 g; fat, 75 g). The same diets and insulin regimens were given during the 24-h period preceding the glucagon infusion, which served as control period.
Arginine and glucose infusions. E.G. and V.B. also received arginine (30 g/30 min) by intravenous infuision as described (11) . Glucose (0.5 g/kg body wt) was given by continuouis intravenous inifusion for 20 min to patient E.G. Patient V.B.
received the same dose as intravenous bolus within 3 mii. Results of intravenous arginine and glucose testing done on patients A.H., E.B., and( E.D. have been published (8) . (Table II) . With the 30-K antiserum, mean basal IRG concentration of nine pancreatectomized patients was 286±101 pg/ml, not significantly different from the 213+46 pg/ml value obtained in 10 normal controls. 1 of 10 controls and 3 of 9 pancreatectomized patients had basal IRG concentrations far exceeding the normal range (50-270 pg/ml in ouir laboratory). Excluding these very high values, mean IRG was 102±15 pg/ml in pancreatectomized patients and 169±10 pg/ml in normal controls. The difference again was not statistically significant. With the RCS-5 antiserum mean basal IRG concentrations was 44±8 pg/mIl in the nine pancreatectomized patients and 70 ±10 pg/ml in the 10 controls (P > 0.05). Molecular species of IRG in pancreatectomized patients (Fig. 1 , Table III ). Sufficient plasma was available from six of the nine pancreatectomized patients to allow identification of molecular IRG species by fractionation over Sephadex G-50 columns and assay of the eluates with both antisera. Using the 30-K antiserum an average of80.8±+-9% of total immunoreactivity eluted within the void volume, whereas 18.3 ±9% eluted in the area of the glucagon marker. Mean plasma 3,500dalton IRG (IRG3500) was calculated to be 18+7 pg/ml. No IRG3500, however, was detected in the plasma of patient C.C. and E.G. By comparison 75.8+±5% of total IRG from five normal controls eluted within the void volume, whereas 24.2±+-5% eluted in the area of the glucagon marker. Mean IRG3500 in normal controls was 49+9 pg/ml, which was significantly greater than that in pancreatectomized patients (P < 0.05).
RESULTS

Basal plasmia IRG
Using the RCS-5 antiserum, all IRG was found in the IRG3500 area in all five patients tested (patient R.B.'s samples were lost and could not be assayed with this antiserum). Small amounts of IRG3500 were detected in patients C.C. and E.G. with the RCS-5 but with not the 30-K antiserum, probably because of the greater sensitivity of the RCS-5 antiserum. Mean plasma IRG35'I was calculated to be 30+6 pg/ml. Recoveries 41%), whereas recoveries of labeled and unlabeled glucagon on the same column were between 85-95%. Fig. 1 illustrates characteristic elution patterns oftwo patients. In patient V.B. (A) 30-K detected 97% of total recovered IRG within the void volume and 3% in the IRG3500 region. Recovery was 93%. RCS-5 measured IRG only in the 3,500-dalton region. Recovery was 31%.
In patient E.G. (Fig. 1B) 30-K detected all recovered IRG within or just outside the void volume (recovery, 87%). RCS-5 again measured IRG exclusively in the 3,500-dalton region with poor recovery (24%). The void volume IRG of three pancreatectomized patients and three normal controls were rechromatographed on Sephadex G-200 (Fig. 2) . The elution patterns ofplasma from pancreatectomized patients and from normal controls were comparable. The large majority of IRG (83% in pancreatectomized patients and 91% in normal controls) eluted with the catalase marker and, thus, had an apparent mol wt of -200,000. This fraction was probably identical with big plasma glucagon, first described by Valverde et al. (21) . Its nature and biological activity are unknown. A second smaller peak (17% in pancreatectomized patients and 9% in normal controls) eluted with the salt marker and, thus, had an apparent mol wt of <5,000. This fraction could have been IRG3500, IRG2000, a salt effect, or a combination of these three.
Plasma IRG after arginine and glucose (Fig. 3 ). Fig.  3 shows data on patients E.B. and V.B. Intravenous infusion of arginine or glucose produced no consistent changes in IRG concentration with the 30-K or RCS-5 antibodies in either patient. Three of the remaining seven patients had previously been studied by Werner et al. (8) . They found that in response to intravenous arginine, IRG (30-K) rose in patient A.H. but did not rise in patients E.D. and R.B. In addition, patients A.H. and R.H. received oral glucose and both responded with a rise in IRG (8) .
Postabsorptive amino acid levels (Table IV) . Concentrations of 19 amino acids were measured in plasma of nine pancreatectomized patients after an overnight fast and before insulin administration. Compared to values from 20 adult normal controls mean concentrations of the following amino acids were significantly elevated: serine, glycine, alanine, arginine, threonine, citrulline, a-aminobutyric acid, and tyrosine. Compared to values obtained from five patients with gastrectomy, the same amino acids were significantly elevated with exception of glycine and tyrosine, where the differences failed to achieve statistical significance. Abnormal elevations were seen most commonly in plasma concentrations of serine and arginine. Both exceeded the normal range in eight of nine patients. Alanine and glycine were elevated in seven of nine and threonine in six of nine patients. Fig. 4 illustrates the day-to-day variation of the elevated amino acids in two patients (E.G. and V.B.), whose Glucagon Deficiency and Hyperaminoacidemia after Pancreatectomy plasma was obtained on three consecuitive days after an overnight fast and before insulin administration. It can be seen that concentrations of alanine, glycine, serine, arginine, threonine, ornithine, tyrosine, and citrulline were repeatedly elevated in one or both patients.
Effect ofglucagon infusion on glucagon, amino acid, and glucose concentrations (Fig. 5 ). In patients E.G. and V.B. physiologic glucagon increments were produced by infusion of exogenous glucagon. During this infusion, IRG concentrations (antiserum RCS-5) rose about 100 pg/ml from basal concentrations of 40 pg/ml to plateau concentrations ofbetween 115 and 165 pg/ml in both patients (Fig. SA) . Patients E.G.'s fasting as well as postprandial blood glucose concentrations (Fig. SB) were within normal limits as were the corresponding values for the day preceding the glucagon infusion, which served as a control period. Patient V.B.'s preinfusion fasting blood glucose was 125 mg/dl. Postlunch and post-dinner values were elevated (>300 mg/ dl), but returned to normal values during the postabsorptive period. A comparable blood glucose pattern had been observed the day preceding the glucagon infusion. Fig. 5C depicts changes of those amino acids that had been consistently elevated. During the first 16 h of glucagon infusion, concentrations of alanine, serine, threonine, arginine, and citrulline declined '251-glucagon marker. while concentrations of tyrosine, proline, and ornithine rose in both patients. The mean of these eight amino acids did not change significantly during this period. Between 16 and 22 h, all eight amino acids decreased sharply in both patients. Mean decreases at the end of the glucagon infusion were 32 and 48% for E.G. and V.B., respectively. Most of the other amino acids were initially normal concentrations also declined but to a lesser extent (10 and 32% for E.G. and V.B., respectively; data not shown).
DISCUSSION
Glucagon deficiency. IRG concentration in plasma has been shown to increase after pancreatectomy in dogs (22) and glucagon indistinguishable from pancreatic glucagon has been extracted from canine stomach and upper intestinal tissues (23,24). There is, however, conflicting evidence as to whether glucagon disappears completely from the blood of totally pancreatectomized humans. Muller et al. (5) found that between 75 and 90 pg/ml of IRG (30-K) remained in plasma of two totally pancreatectomized patients. Between 15 and 35 pg/ml of this could be bound to charcoal and, therefore, was suspected to be "true glucagon". Werner et al. (8) found between 48 and 189 pg/ml of IRG (30-K) in plasma from six pancreatectomized patients. After acetone 710 Boden, Master, Rezvani, Palmer, Lobe, and Owen extraction, which presumably eliminated the large molecular weight IRG species, these values decreased to between 35 and 60 pg/ml (mean, 46 pg/ml). Barnes and Bloom, however, using their RCS-5 antisertum found no IRG in plasma of five pancreatectomized patients (4). The differences in results between their and other studies may be explainable, at least in part, by differences in methodology. Barnes and Bloom ran each patient's standard curve with plasma rendered "glucagon free" by pretreatment with an immunoabsorbent. However, it is likely that this plasma still contained IRG because the immunoabsorbent was equilibrated with antiserum that reacted with large molecular weight IRG weakly or not at all (see below). Thus, by adding the "stripped plasma" they may have created an arbitrary 0 standard, which led to underestimation of plasma IRG. In agreement with Muller et al. (5) and Werner et al., (8) we found IRG (30-K) in plasma of all of our nine pancreatectomized patients. Our mean IRG value was higher than theirs largely because of very high IRG concentrations in three patients (C.C., A.H., and E.G.). Frac-tionation over Sephadex G-50 of plasma from two ofthe three (C.C. and E.G.) revealed that 95 and 100% oftheir IRG, respectively, consisted of large molecular weight material ( Fig. 1 and Table III ). The cauise and significance of these excessive IRG concentrations, also present in 1 of 10 controls, remnains obscure. In contrast to Barnes and Bloom, we detected IRG in eight of nine pancreatectomized patients by using their antiserum (RCS-5). Our gel filtration data revealed that neither of the two antisera accurately measured "authentic" glucagon (IRG3500) in plasma. When 30-K was used, most of the IRG in pancreatectomnized patients (8 1%) and in normal subjects (76%) eluted within the void volume. Rechromatography over Sephadex G-200 (Fig. 2 ) showed that this IRG had an apparent molecular weight of -200,000. This IRG species is probably identical with big plasma glucagon, first described by Valverde et al. (21) . Its exact nature and bioactivity are unknown. Only 18% of IRG (range, 0-58%) in pancreatectomnized patients and 24% of IRG (range, 9-34%) in normal subjects Glucagon Deficiency and Hyperarninoacideinia after Pancreatectoyny 711 eluted in the 3,500-dalton area, which presently is the When the RCS-5 antiserum was used, all IRG eluted only glucagon species with proven bioactivity (25) . in the 3,500-dalton region, provided lyophilized plasma Thus, most of the IRG measured with the 30-K antiserum was employed for fractionation. However, column rein plasma consisted of a large molecular weight fraction, coveries were low (45%). There are two possible exthe bioactivity of which is uncertain. of plasmna IRG with 30-K (Table III) , '251-glucagon, and crystalline glucagon, were all satisfactory (>85%) on the same column. In addition, the amount of IRG3500 recovered with both 30-K and RCS-5 antisera was comparable (18 vs. 20 pg/ml). This indicated that IRG was not lost during passage through the column and that the poor recoveries may have been the result of falsely high IRG measurements in unfractionated plasma. A likely mechanism for this could have been nonspecific interactions between plasma proteins and the RCS-5 antiseruim. Secondly, the RCS-5 antiserum measured IRG3500 specifically only if lyophilized plasma was used for fractionation. When native plasma was fractionated, the antibody detected void volume IRG, albeit in much smaller amounts than the 30-K antiserum (data not shown). As a result, RCS-5, when used with native plasma, probably measured a small amount of large molecular weight IRG and, in addition, may have overestimated IRG concentration because of nonspecific protein interaction. Gel fractionation revealed unequivocally that there was IRG350 present in plasma ofall six pancreatectomized patients that were studied. In two of the six (C.C. and E.G.) IRG3500 was not found with the 30-K but was detected with the RCS-5 antiserum, which was more sensitive. Our results are comparable to those reported by Botha et al. (7) who fractionated plasma of one pancreatectomized patient and found large molecular weight IRG and IRG3500. These findings indicated that pancreatectomized patients are not aglucagonemic, as postulated by Barnes and Bloom (4) and, therefore, cannot serve as model for diabetes without glucagon. They also demonstrated that both antisera are not specific for pancreatic glucagon and that the commionly used designation "pancreatic glucagon specific" antiserumn is a misniomiier. The source for the extrapancreatic glucagoni was probably the fundic mucosa, most of which was not removed during hemigastrectomy.
Mean IRG3500 (30-K) was significantly smaller in pancreatectomized patients than in normal controls (18+7 vs. 49±9, P < 0.05). There was, however, a wide range of basal IRG3500 values in these patients (from 10 to 38 pg/ml), which probably reflected varying amounts of remaining upper intestinal tissue. For instance, the lowest IRG concentrations were found in three patients (C.C., V.B., and E.G.) who had lost part of their jejunum in addition to total duodenectomy, pancreatectomy, and partial gastrectomy.
Most of the patients studied by us and others (4-7) showed little or no IRG responses to stimulation with arginine. Similar data have been reported in pancreatectomized dogs, where it has been shown that arginine stimulated release of IRG only if the animnals were severely insulin deficient (26, 27) . Thus, our data, although obtained from a relatively small number of patients, suggested, that the pancreatectomized patients were partially glucagon deficient as result of reduced basal IRG concentrations associated with absent or subnormal IRG responses to stimulation. Moreover, because glucagon concentrations are higher in the portal than in the peripheral circulation, glucagon deficiency in these patients must have been most pronounced at the liver, which is the major target organ for glucagon.
Hyperaininoacidemnia. In this study it was found that total pancreatectomy was associated with chronic hyperaminoacidemiia in all nine patients studied. Postabsorptive plasma concentrations of serine, alanine, arginine, glycine, threonine, citrulline, a-aminobutyric acid, and tyrosine were significantly elevated compared to normal controls (Table IV) . The most prominent and consistent elevations were seen in plasma levels of serine, alanine, arginine, and glycine. Recognized causes for hyperaminoacidemia such as obesity (4) , and diurnal variation of amino acid levels (27) , could be ruled out in these patients. All, except one patient, were nonobese and the pattern of amino acids observed were totally unlike that seen in obesity (4) . Blood samples for amino acid determinations were drawn from patients patients suggested that these patients were insulin deficient at the time of the study and that this may have altered amino acid levels. However, insulin deficiency characteristically results in elevations of the branchedchained amino acids (leucine, isoleucine, and valine) and diminished concentrations of some glycogenic amnino acids, particularly of alanine (28, 12) as result of increased splanchnic uptake of these amino acids (29) . This pattern was not present in any of our patients. In fact, eight of nine had markedly elevated alanine concentrations and branched-chain amino acids were within normal limits in all nine. Four of nine patients were undernourished (<90% of ideal weight). The causes incltuded postprandial discomfort caused by abdominal adhesions, stubclinical maldigestion despite replacement therapy with pancreatic enzymes and recurrent and/or metastatic malignancy. However, amnino acid profiles observed in our patients bore little resemblance to those found in various states of malnutrition. For instance, Smitlh et al. (30) have reported that patients with chronic severe protein-calorie malnutrition showed severe depression of all essential amino acids. Of the nonessential amino acids a-aminobutyric acid, one-half cystine, tyrosine, histine, and arginine were all depressed, whereas the remaining amino acids were unchanged except for glycine, which was elevated. A similar pattern was founid in normnal subjects after 7-10 d of protein-free diet (31). All essential amiiino acids declined, whereas glycine and alanine rose. Felig et al. (16) , upon studying obese healthy subjects, reported that 5-6 wk of total starvation led to a generalized decline in plasma amino acids, in which the fall of alanine was most prominent. Adibi (32) also observed a fall in alanine in normal subjects after 2 wk of total starvation. Moreover, our underweight, normal, and overweight pancreatectomized patients all demonstrated the same type of ainino acid abnormalities, which makes it unlikely that these changes were cauised by malnutrition.
On the other hand, our pancreatectomized patients were partially glucagon deficient. This may be expected to lead to hyperaminoacidemia, inasmuch as the opposite condition, glucagon hypersecretion, in patients with glucagonoma invariably results in severe hypoaminoacidemia (10, 11) . Similarly, infusion of supraphysiologic doses of glucagon has been shown to restult in decreases of many amino acids with alanine showing the greatest decline (33), and infusion of physiological doses of glucagon (4.2 ,g/h x 24 h) into 4-6 wk fasted subjects resulted in small decreases in alanine, serine, proline, threonine, ornithine, tyrosine, and one-half cystine (14) . The observation in this study that small glucagon increments normalized previously elevated amino acid concentrations in two patients are compatible with, but do not prove a cause and effect relationship between, glucagon deficiency and hyperaminoacidemia. It cannot be excluded that the glucagon infusion produced mild portal hyperglycagoinemia, which in turn 714 Boden, Master, Rezvani, Palmer, Lobe, and Owen inay have been responsible for the fall in plasma amino acid concentrations. Our recent observation, however, that acute selective glucagon deficiency, produced in normal subjects by infusion of somatostatin plus insulin, led to significant increases in plasma concentrations of glycine, alanine, arginine, glutamine, and lysine within 8 h (34) further strengthened the concept that glucagon deficiency produces hyperaminoacidemia.
Our studies provide no information on how glucagon deficiency leads to hyperaminoacidemnia. Experiments showing that glucagon infusion stimulated (35) and glucagon deficiency inhibited gluconeogenesis from alanine, (36) suggested alteration in the rate of gluconeogenesis from amino acids as the mechanism by which glucagon can control blood amino acids levels. In support of this thesis are our findings that (a) the most prominent elevations occurred in plasma concentration ofthose amino acids (alanine, glycine, serine, threonine) that are most avidly extracted by the splanchnic bed (37) and (b) that acute selective glucagon deficiency in normal subjects significantly decreased urinary urea exeretioni (34). Lastly, it is noteworthy that those amino acids that are potent stimnulators of glucagon release, (particularly alanine, and arginine) are also most affected by its metabolic actions. This suggests the existence of a feedback system between glticagon and certain glycogenic amino acids. ADDENDUNI While this mnanuiiscript was tunder review, Muller et al. (1979. J. Clin. Intvest. 63: 820-827.) published data showing signiificant elevations of plasma alanine, serine, ornithine, and arginine in five patients with duodenopancreatectomy. In eight duodenectomized, pancreatectomized patients basal IRG (30-K) was 162+±68 pg/ml and did not change during the arginine infusion period. Bio-Gel P-30 column chromatography revealed that virtuially all IRG had a mol wt of >3,500. Their failure to detect IRG3500 in all but one patient seems clearly related to the relative insensitivity of their assay system. Muller et al. meastured IRG in 0.2 ml of eluiate with a sensitivity of 20 pg/mIl of eluate, whereas we used 0.9 ml of eluate with a sensitivity of 6 pg/mIl of eluate. Ouir data indicate that IRG3500 concentrations in pancreatectomized patients are too simiall to be detected by an assay system with a sensitivity of 20 pg/mIl. Glucagon Deficiency and Hyperaminoacidemnia after Pancreatectomny 715
